Other Guidelines & Standards

The International collaboration of transfusion medicine guidelines (ICTMG)

The ICTMG or International Collaboration for Transfusion Medicine Guidelines, was established in 2011 and includes international transfusion experts. The goal of the ICTMG is to create and promote evidence-based clinical guidelines to optimize transfusion medicine.

Several ANZSBT members are also members of ICTMG and have been co-authors of the guidelines. ANZSBT members may find visiting the ICTMG website helpful and of interest:


Patient Blood Management Guidelines

The Patient Blood Management Guidelines are a suite of six evidence-based, NHMRC-approved modules focusing on patient blood management. A Clinical/Consumer Reference Group was established for each module, comprising representatives from relevant clinical colleges and societies, including ANZSBT. The guidelines are available on the National Blood Authority’s website.


  1. Critical Bleeding/Massive Transfusion
  2. Perioperative
  3. Medical
  4. Critical Care
  5. Obstetrics and Maternity
  6. Neonatal and Paediatrics

Other Guidelines

National Safety and Quality Health Service Standards (second edition), November 2017
Australian Commission on Safety and Quality in Health Care

Guidelines for the management of haemophilia in Australia, July 2016
Australian Haemophilia Centre Directors’ Organisation in collaboration with the National Blood Authority.

An update of consensus guidelines for warfarin reversalMarch 2013
Australasian Society of Thrombosis and Haemostasis

Medical refrigeration equipment – For the storage of blood and blood products – Manufacturing requirements
AS 3864.1-2012 , November 2012
Standards Australia

Medical refrigeration equipment – For the storage of blood and blood products – User-related requirements for care, maintenance, performance verification and calibration AS 3864.2-2012, November 2012
Standards Australia

Guidelines for Management of Factor VII Deficiency, May 2010
Australian Haemophilia Centre Directors’ Organisation

Evidence-based clinical practice guidelines for the use of recombinant and plasma-derived FVIII and FIX products, June 2006
Australian Health Ministers’ Advisory Council